At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
PRFX PainReform
Market Closed 12-20 16:00:00 EST
5.30
-5.86
-52.51%
盘后4.88
-0.42-7.92%
19:59 EST
High7.87
Low4.55
Vol2.94M
Open6.56
D1 Closing11.16
Amplitude29.75%
Mkt Cap4.64M
Tradable Cap4.48M
Total Shares874.90K
T/O17.00M
T/O Rate347.55%
Tradable Shares845.60K
P/B--
ROE--
EPS0.00
52wk High--
52wk Low--
P/E--
Dividend--
Div.Yield--
ROA--
Dow Surges 100 Points, Carnival Earnings Top Views
PainReform Ltd., a clinical stage specialty pharmaceutical company, engages in the development of therapeutics that provides an extended period of post-surgical pain relief in Israel. The company engages in developing PRF-110, a viscous clear oil-based solution that is instilled directly into the surgical wound to provide localized and extended post-operative analgesia. It is currently conducting Phase 3 clinical trials of PRF-110 for the treatment of patients undergoing bunionectomy surgery and hernia repair. The company was incorporated in 2007 and is based in Tel Aviv, Israel.